Collagen architecture

Show results for

Unknown (751)
Transcriptomics (87)
Genomics (82)
Proteomics (15)
Other (5)
Metabolomics (1)

Organisms

Homo sapiens (54)
Mus musculus (41)
Andropogon gerardi (13)
Bacteria (13)
Bartonella quintana JK 31 (13)
Canis lupus familiaris (13)
Clavibacter nebraskensis NCPPB 2581 (13)
Cnidaria (13)
Ensifer adhaerens (13)
Halictus scabiosae (13)
Human alphaherpesvirus 1 strain 17 (13)
Human alphaherpesvirus 1 strain KOS (13)
Human betaherpesvirus 5 (13)
Human herpesvirus 2 strain 186 (13)
Mesocricetus auratus (13)
Miscanthus x giganteus (13)
Mus musculus (13)
Panicum virgatum (13)
Plasmodium falciparum (2)
Capra hircus (1)
Schizosaccharomyces pombe (1)
Caenorhabditis elegans (1)
Escherichia coli str. K-12 substr. MG1655 (1)
Sus scrofa (1)
Sander lucioperca (1)
Sus scrofa domesticus (1)
Drosophila melanogaster (1)
Gallus gallus (1)
Ovis aries (1)
Rattus norvegicus (1)

Organisms

Homo sapiens (28)
Mus musculus (26)
Sander lucioperca (1)
Drosophila melanogaster (1)
Ovis aries (1)
Sus scrofa domesticus (1)

Repository

ENA (68)
geo (53)
biostudies-arrayexpress (46)
pride (13)
EGA (6)
GPMDB (1)
iProX (1)
MassIVE (1)
MetaboLights (1)

Tissue

Cell culture (3)
Fibroblast (3)
Breast (2)
Lung (2)
Brain (1)
Heart (1)
Intestine (1)
Skeletal muscle (1)

Disease

Breast cancer (2)
Not Available (1)
Cardiovascular system disease (1)

Technology Type

Mass Spectrometry (13)
Bottom-up proteomics (5)
Shotgun proteomics (3)
Data-dependent acquisition (2)
Data-independent acquisition (2)
Mass spectrometry imaging (2)
Human Cardio Metabochip (1)
Mass spectrometry assay (1)
Gel-based experiment (1)
Top-down proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (5)
Illumina HiSeq 2500 (2)
Illumina HiSeq 4000 (2)
Chromium™ Next GEM Single Cell 3′ Kit v3.1 (10X Genomics, PN-1000269) (1)
HiSeq 2000 (1)
Not applicable (1)
Illumina NovaSeq X (1)
N/A (1)
Instrument (1)
Orbitrap Exploris 480 (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2026 (31)
2025 (16)
2024 (9)
2013 (9)
2021 (8)
2023 (7)
2015 (7)
2010 (7)
2009 (4)
2019 (3)
2016 (2)
2014 (2)
2011 (2)
2008 (2)
2022 (2)
2017 (2)
2012 (1)

Metabolite Name

TG(O-16:0_16:0_20:4) (1)
TG(9:0_18:1_18:2) (1)
TG(9:0_16:0_18:2) (1)
TG(8:0_16:0_18:3) (1)
TG(8:0_16:0_18:1) (1)
TG(8:0_16:0_16:0) (1)
TG(8:0_14:0_18:2) (1)
TG(8:0_14:0_18:1) (1)
TG(8:0_14:0_18:0) (1)
TG(8:0_14:0_16:0) (1)
TG(24:0_18:1_20:1) (1)
TG(20:1_22:1_18:4) (1)
TG(20:0_18:1_22:5) (1)
TG(18:2_20:3_22:5) (1)
TG(18:2_20:2_22:6) (1)
TG(18:2_18:3_18:4) (1)
TG(18:1_21:1_18:2) (1)
TG(18:1_20:1_22:4) (1)
TG(18:1_18:3_22:3) (1)
TG(18:1_18:2_24:5) (1)
TG(18:1_18:2_22:2) (1)
TG(18:1_18:1_24:4) (1)
TG(18:0_20:1_22:0) (1)
TG(18:0_18:1_22:5) (1)
TG(18:0_18:1_20:3) (1)
TG(17:2_18:2_18:3) (1)
TG(17:1_19:2_19:2) (1)
TG(17:1_18:1_22:2) (1)
TG(17:1_18:1_20:4) (1)
TG(17:0_18:3_18:3) (1)

First Public Date

2026 (25)
2025 (15)
2023 (7)
2024 (6)
2021 (5)
2022 (3)
2019 (3)
2017 (3)
2018 (1)

Study type

Transcription profiling by array (20)
RNA-seq of coding RNA (10)
ChIP-seq (4)
Other (2)
RNA-seq of coding RNA from single cells (2)
RNA-seq of non coding RNA (2)
Unknown experiment type (1)
ChIP-chip by tiling array (1)
Cell line - High-throughput sequencing (1)
Spatial transcriptomics by high-throughput sequencing (1)
4C (1)
Hi-C (1)

Release Date

2025 (85)
2022 (85)
2021 (78)
2024 (70)
2023 (66)
2020 (63)
2019 (52)
2018 (49)
2017 (38)
2015 (36)
2026 (32)
2016 (29)
2013 (23)
2014 (19)
2010 (17)
2011 (14)
2012 (12)
2009 (12)
2008 (9)
2006 (3)
2007 (2)
2005 (1)
2002 (1)
2001 (1)

Lab affiliation

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr Aiguader 88, Barcelona 08003, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; ICREA, Pg. Lluis Companys 23, Barcelona 08010, Spain (1)
Dept. of Pharmacology Basic Science Building, Rm 306 Medical University of South Carolina United States of America (1)
Fondazione Ri.Med Department of Laboratory Medicine and Advanced Biotechnologies, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IRCCS - ISMETT) Via Ernesto Tricomi, 5 - 90127 Palermo (1)
Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Athens/Greece (1)
Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center AlexanderFleming, Athens/Greece. (1)
Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne Germany; Center for Molecular Medicine (CMMC), University of Cologne, 50931 Cologne, Germany (1)
Institute of Physiology, Czech Academy of Sciences (1)
Laboratory of Cardiovascular Medicine, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy (1)
Pharmacology Department; Angel Lab; Medical University of South Carolina; United States of America (1)
Research Group of Developmental Disorders and Rare Diseases, Korea Brain Research Institute (KBRI), Daegu 41062, Republic of Korea (1)
TIGEM (1)
UniCamillus (1)
Laboratoire MSAP UAR 3290 CNRS Bâtiment C4 Avenue Paul Langevin Cité Scientifique 59655 Villeneuve D'ascq 03 20 33 71 12 https://msap-lab.fr/ (1)

Previous page
1 / 95
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 95
Next page

Sort by:

Relevance

Page size

A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer

The assessment of global changes in fibrillar collagens and to the larger extent e.g., ECM induced upon inhibitor treatment has largely been lacking for the currently available LOX family inhibitors. We therefore undertook a quantitative pharmacodynamics approach to characterize the global alteratio...

ORGANISM(S): Mus musculus (Mouse)

2025-12-01 | PXD052642 | Pride

A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer

Raw proteomic files Metin C, Saatci O, Rezaeian A-H, Rao CN, Beneker C, Taylor H, Pederson B, Chatzistamou I, Buckley B, Lessner S, Angel P, McInnes C, Sahin O. A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer. Ce...

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

2024-05-16 | MSV000094776 | MassIVE

Association of collagen architecture with glioblastoma patient survival.

Not available

S-EPMC5386834 | biostudies-literature

Prostatic collagen architecture in neutered and intact canines.

Not available

S-EPMC6356104 | biostudies-literature

Photo-active collagen systems with controlled triple helix architecture.

Not available

S-EPMC4934656 | biostudies-literature

Coherency image analysis to quantify collagen architecture: implications in scar assessment.